These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27095876)

  • 21. Amoxicillin/clavulanate potassium extended release tablets: a new antimicrobial for the treatment of acute bacterial sinusitis and community-acquired pneumonia.
    Benninger MS
    Expert Opin Pharmacother; 2003 Oct; 4(10):1839-46. PubMed ID: 14521493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group.
    Mandell LA; Marrie TJ; Grossman RF; Chow AW; Hyland RH
    Clin Infect Dis; 2000 Aug; 31(2):383-421. PubMed ID: 10987698
    [No Abstract]   [Full Text] [Related]  

  • 23. Evolution of acute infection with atypical bacteria in a prospective cohort of children with community-acquired pneumonia receiving amoxicillin.
    Nascimento-Carvalho CM; Xavier-Souza G; Vilas-Boas AL; Fontoura MH; Barral A; Puolakkainen M; Ruuskanen O;
    J Antimicrob Chemother; 2017 Aug; 72(8):2378-2384. PubMed ID: 28475737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae.
    Siquier B; Sánchez-Alvarez J; García-Mendez E; Sabriá M; Santos J; Pallarés R; Twynholm M; Dal-Ré R;
    J Antimicrob Chemother; 2006 Mar; 57(3):536-45. PubMed ID: 16446376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Community-acquired pneumonia in children: importance of Mycoplasma pneumoniae infections and efficacy of antibiotics].
    Gendrel D; Raymond J; Moulin F; Iniguez JL; Truong M; Ravilly S; Chaussain M; Lebon P; Kalifa G
    Presse Med; 1996 May; 25(17):793-7. PubMed ID: 8762275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone.
    Rosón B; Carratalà J; Tubau F; Dorca J; Liñares J; Pallares R; Manresa F; Gudiol F
    Microb Drug Resist; 2001; 7(1):85-96. PubMed ID: 11310807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical failure among children with nonsevere community-acquired pneumonia treated with amoxicillin.
    Fontoura MS; Araújo-Neto CA; Andrade SC; Brim RV; Matutino AR; Silva CC; Santana MC; Nobre-Bastos M; Oliveira F; Barreto BB; Santos PM; Noblat L; Cardoso MR; Nascimento-Carvalho CM;
    Expert Opin Pharmacother; 2010 Jun; 11(9):1451-8. PubMed ID: 20408745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-course antimicrobial therapy for paediatric respiratory infections (SAFER): study protocol for a randomized controlled trial.
    Pernica J; Harman S; Kam A; Bailey J; Carciumaru R; Khan S; Fulford M; Thabane L; Slinger R; Main C; Smieja M; Loeb M
    Trials; 2018 Feb; 19(1):83. PubMed ID: 29391051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
    White AR; Kaye C; Poupard J; Pypstra R; Woodnutt G; Wynne B
    J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial.
    Hazir T; Fox LM; Nisar YB; Fox MP; Ashraf YP; MacLeod WB; Ramzan A; Maqbool S; Masood T; Hussain W; Murtaza A; Khawar N; Tariq P; Asghar R; Simon JL; Thea DM; Qazi SA;
    Lancet; 2008 Jan; 371(9606):49-56. PubMed ID: 18177775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Epidemiology of community-acquired pneumonia in children aged less than 5 years old in the Autonomous Community of Valencia (Spain)].
    Garcés-Sánchez MD; Díez-Domingo J; Ballester Sanz A; Peidró Boronat C; García López M; Antón Crespo V; Peris Vidal A; Baldo Poblet JM; Gallego García D
    An Pediatr (Barc); 2005 Aug; 63(2):125-30. PubMed ID: 16045871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zinc for Acute Diarrhea and Amoxicillin for Pneumonia, Do They Work? : Delivered at the AIIMS, IJP Excellence Award for the year 2013 on 7th September 2014.
    Patel A
    Indian J Pediatr; 2015 Aug; 82(8):703-6. PubMed ID: 25731896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative evaluation of cefixime versus amoxicillin-clavulanate following ceftriaxone therapy of pneumonia.
    Amir J; Harel L; Eidlitz-Markus T; Varsano I
    Clin Pediatr (Phila); 1996 Dec; 35(12):629-33. PubMed ID: 8970755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variability in Antibiotic Prescribing for Community-Acquired Pneumonia.
    Handy LK; Bryan M; Gerber JS; Zaoutis T; Feemster KA
    Pediatrics; 2017 Apr; 139(4):. PubMed ID: 28270546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Clarithromycin and Amoxicillin/Clavulanic Acid for Community-Acquired Pneumonia in an Era of Drug-Resistant Streptococcus pneumoniae.
    Bonvehi P; Weber K; Busman T; Shortridge D; Notario G
    Clin Drug Investig; 2003; 23(8):491-501. PubMed ID: 17535061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amoxicillin plus temocillin as an alternative empiric therapy for the treatment of severe hospital-acquired pneumonia: results from a retrospective audit.
    Habayeb H; Sajin B; Patel K; Grundy C; Al-Dujaili A; Van de Velde S
    Eur J Clin Microbiol Infect Dis; 2015 Aug; 34(8):1693-9. PubMed ID: 25987247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical management of community-acquired pneumonia in young children.
    Nascimento-Carvalho AC; Nascimento-Carvalho CM
    Expert Opin Pharmacother; 2019 Mar; 20(4):435-442. PubMed ID: 30507273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of β-Lactam Monotherapy vs Macrolide Combination Therapy for Children Hospitalized With Pneumonia.
    Williams DJ; Edwards KM; Self WH; Zhu Y; Arnold SR; McCullers JA; Ampofo K; Pavia AT; Anderson EJ; Hicks LA; Bramley AM; Jain S; Grijalva CG
    JAMA Pediatr; 2017 Dec; 171(12):1184-1191. PubMed ID: 29084336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gemifloxacin once daily for 7 days compared to amoxicillin/clavulanic acid thrice daily for 10 days for the treatment of community-acquired pneumonia of suspected pneumococcal origin.
    Léophonte P; File T; Feldman C
    Respir Med; 2004 Aug; 98(8):708-20. PubMed ID: 15303634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Penicillin and gentamicin therapy vs amoxicillin/clavulanate in severe hypoxemic pneumonia.
    Bansal A; Singhi SC; Jayashree M
    Indian J Pediatr; 2006 Apr; 73(4):305-9. PubMed ID: 16816491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.